In an interview with Applied Clinical Trials Associate Editor Don Tracy, Samuel Salvaggio Senior Trial Design Lead, One2Treat, discusses partnerships that remain vital for guaranteeing success in ...

Flourish is an Apex, North Carolina-based multi-site clinical trial organization focused primarily on cardiovascular, metabolic, neuroscience, and infectious disease therapeutic areas.

CluePoints named as Finalist in 2025 ACDM AwardsThe Company, along with its Research and Development Teams, were shortlisted for continuing its mission of turning artificial intelligence into a force ...

CBD has shown promise as a treatment for psychosis in small studies and case reports. A large, international trial launching ...

Johnson & Johnson, a leader in immunology, has developed ARGES, a new AI-powered tool that could transform endoscopic ...

Join the inaugural 1000 Miglia Experience Italy, showcasing Southern Italys UNESCO sites from April 11-12, 2025. Register by ...

The US Food and Drug Administration (FDA) has granted fast track designation to Rznomics' RZ-001 for the treatment of ...

- Average microdystrophin expression of 110% (N=3) and significant improvements in multiple additional muscle health ...

D Molecular Therapeutics is undervalued, with its lead candidate 4D-150 showing potential. Click here to find out why I rate ...

We assign Siegfried a Medium Morningstar Uncertainty Rating. Its business is relatively stable, with high switching costs and good visibility due to long-term customer contracts. However, small ...

Lebanon Plan Commission on Monday night unanimously approved a design plan for Eli Lilly and Co.’s $4.5 billion center for advanced manufacturing and drug development at the LEAP Research and ...

Fears have been raised over plans for a new Oxford hospital building over its proximity to the Lye Valley. Oxford University is seeking planning permission from the city council to introduce a modular ...